Safic-Alcan distributes pharmaceutical raw materials through its subsidiaries in France, Spain and China. With more than 50 years of commitment to innovation, cost-effectiveness and high service levels in pharmaceuticals, the Company has gained its reputation as a preferred distributor and developed exclusive partnerships with major international raw materials producers and drug manufacturers.
Safic-Alcan’s full range of pharmaceutical raw materials and services include:
- API (Active Pharmaceutical Ingredients)
- Additives (mainly from China and India)
- Plant extracts
- product evaluation
- regulatory compliance
- logistics and storage
- international delivery
In France, Safic-Alcan operates through 3 different channels: Safic-Alcan France, BIM Sifram and Biochimex.
Safic-Alcan France provides active pharmaceuticals ingredients (APIs) and excipients from first class manufacturers worldwide. Our value added is the expertise of our dedicated team in sourcing and supply. From market knowledge to the ability to provide solutions at each stage of the projet such as API research, development, formulation, product assessment, regulatory compliance, logistics, storage certified ANSM or pharmaceutical business. Our tailored to customers’ service allowed us to develop preferred and exclusive partnerniships with major French manufacturers.
We cover the entire French territory including Monaco.
BimSiframGroup (BSG) is is Safic-Alcan’s Sino-French subsidiary headquartered in Paris La-Défense with premises in Chengdu and Beijing (China). BSG is specialised in the production and distribution of plant extracts, active ingredients, chemical intermediates and biochemical products.
The headquarters are located in Paris La-Défense with subsidiaries in Chengdu and Beijing (China). The multicultural team consists of experts in chemistry, pharmacy, international trade and finance.
Founded in 1986, BSG has quickly developed and became an important player in the trade with China, who is strongly present in pharmaceutical, veterinary, chemical, food and cosmetic industry.
Biochimex is our latest extension line for pharmaceuticals in France. It is specialized in micronization and sterilization of betalactams. With this range of products, Biochimex is present all over the world in both human and veterinarian markets. The company is also an API and excipients distributor for Maghreb and South Africa.
Safic-Alcan Especialidades, Safic-Alcan’s Spanish subsidiary, has a leading position on the Spanish pharmaceuticals market. The Company offers the fullest range of excipients for solid and liquid forms as well as a wide range of exclusive synthesis intermediaries and active principals. The company has also a solid presence in the veterinary sector thanks to its recognised range of adjuvants for (biological) vaccine manufacture as well as excipients for injectable liquid and solid (pharmacological) forms, antibiotics and active principals from Asia, through HuaFaMei.
HuaFaMei is Safic-Alcan’s subsidiary in China. It is considered as the professional trader, agent and distributor of APIs, intermediate, plant extracts, chemical raw materials, drug products. HuaFaMei commits to guarantee the traceability of its products from export and import to final distribution and the reliability of its sourcing procedures. The product range includes Glycine, L-Alanine, L-Aspartic Acid, L-Cysteine, L-Leucine, L-Phenylalanine, Acetylcysteine... They provide high quality and fast consulting services as well as analytical laboratory services (GLP) to pharmaceutical companies from all over the world.
HuaFaMei employs 45 multicultural experts in chemistry, pharmacy, international trade and finance. They provide high quality and fast consulting services as well as analytical laboratory services (GLP) to pharmaceutical companies from all over the world.
Moreover, HuaFaMei’s Quality Assurance & Registration Affairs Department (QARAD) has a state-of-the art laboratory center in Sichuan University and a long term relationship with European pharmaceutics experts.
HuaFaMei is certified ISO 9001:2000. Its Quality Assurance & Registration Affairs Department (QARAD) has a state-of-the art laboratory center in Sichuan University and a long term relationship with European pharmaceutics experts.
Marmara Ecza is our latest acquisition in Turkey and a major player for pharmaceuticals with a very large range of excipients. Marmara Ecza collaborates with HuaFaMei to develop APIs in the region.
Safic-Alcan’s strategy for pharmaceuticals is to maintain its strong market presence in the countries that it already covers such as France, Italy, Spain, Portugal, the UK, the Maghreb countries (Algeria, Tunisia, Morocco) and Turkey and to fill its portfolio gap by strengthening and consolidating its worldwide position through organic expansion or by acquisitions.